Wei Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wei Wei has a total of 389 co-authors. Here are the top co-authors by number of shared publications:
Alicia Mejia
41 shared publications- Bradley M. Broom
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
41 shared publications - Dipen Maheshbhai Maru
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
41 shared publications Hector A. Alvarez
41 shared publicationsHuiqin Chen
41 shared publicationsJeffrey S. Morris
41 shared publications
Latest Publications
- Open Access
- 5 September 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e201
A case-control study of end-of-life antimicrobial use in Non-hospitalized hospice patients in the United States
Background: Antimicrobials are frequently prescribed to hospice patients despite limited data on their utility.1–3 The Palliative Performance Scale (PPS) has been used for survival prediction among cancer patients and further generalized to end-of-life (EOL) diagnoses.4 This study aims to identify characteristics associated with antimicrobial usage within 30 days of EOL in non-hospitalized outpatient hospice patients from a single center in the United States (US). Methods/study design: We analyzed data on 1,111 hospice deaths from 2019. From these data, patients were divided into two groups: those who received antimicrobials at EOL (n = 212) and equally randomly computer-generated control group who did not. Fisher’s exact test and Wilcoxon rank sum test were used for analysis. PPS was recorded and used to determine functional status; higher PPS equates to higher functional status. Multivariable logistic regression correlated patient characteristics with EOL antimicrobial status. Results: Higher PPS scores were significantly associated with increased likelihood of antimicrobial use (Odds Ratio [OR] 1.40, 95% Confidence Interval [CI] 1.16–1.70). Male patients (OR 0.60, 95% CI 0.40–0.90) and patients with cancer (OR 0.61, 95% CI 0.39–0.96) were associated with lower odds of receiving antimicrobials. No significant association was found with age, race/ethnicity, residence, illness, or code status. Conclusion: The study identifies an association between PPS and antimicrobial prescribing near EOL. Tailoring antimicrobial use based on individual patient characteristics and goals may better align with hospice care objectives and aid in stewardship endeavors. Further research is needed to explore PPS as a potential tool to guide prescribing.
- 5 September 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e201
Open AccessA case-control study of end-of-life antimicrobial use in Non-hospitalized hospice patients in the United States
Background: Antimicrobials are frequently prescribed to hospice patients despite limited data on their utility.1–3 The Palliative Performance Scale (PPS) has been used for survival prediction among cancer patients and further generalized to end-of-life (EOL) diagnoses.4 This study aims to identify characteristics associated with antimicrobial usage within 30 days of EOL in non-hospitalized outpatient hospice patients from a single center in the United States (US). Methods/study design: We analyzed data on 1,111 hospice deaths from 2019. From these data, patients were divided into two groups: those who received antimicrobials at EOL (n = 212) and equally randomly computer-generated control group who did not. Fisher’s exact test and Wilcoxon rank sum test were used for analysis. PPS was recorded and used to determine functional status; higher PPS equates to higher functional status. Multivariable logistic regression correlated patient characteristics with EOL antimicrobial status. Results: Higher PPS scores were significantly associated with increased likelihood of antimicrobial use (Odds Ratio [OR] 1.40, 95% Confidence Interval [CI] 1.16–1.70). Male patients (OR 0.60, 95% CI 0.40–0.90) and patients with cancer (OR 0.61, 95% CI 0.39–0.96) were associated with lower odds of receiving antimicrobials. No significant association was found with age, race/ethnicity, residence, illness, or code status. Conclusion: The study identifies an association between PPS and antimicrobial prescribing near EOL. Tailoring antimicrobial use based on individual patient characteristics and goals may better align with hospice care objectives and aid in stewardship endeavors. Further research is needed to explore PPS as a potential tool to guide prescribing.
- Open Access
- 15 July 2025
- Published by Elsevier in Blood Neoplasia
- Vol. 2 (4)
Deferring treatment in hairy cell leukemia: is active surveillance safe?
- 15 July 2025
- Published by Elsevier in Blood Neoplasia
- Vol. 2 (4)
Open AccessDeferring treatment in hairy cell leukemia: is active surveillance safe?
- Open Access
- 31 July 2024
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 22 (6) , 102181
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
- 31 July 2024
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 22 (6) , 102181
Open AccessPhase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
- Open Access
- 9 February 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (5) , 534.e1-534.e13
Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation
- 9 February 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (5) , 534.e1-534.e13
Open AccessFertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation
- 12 September 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (12) , 1384-1389
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma
Recently there has been a growing interest in evaluating body composition as a marker for prognosis in cancer patients. The association of body composition parameters and outcomes has not been deeply investigated in patients with autologous hematopoietic stem cell transplantation (HSCT) recipients with non-Hodgkin lymphoma (NHL). We conducted a retrospective cohort study of 264 NHL patients who received autologous HSCT. PreHSCT abdominal CT scans at the levels of L3 were assessed for body composition measures. We evaluated sarcopenia, myosteatosis, high visceral adipose tissue (VAT) and high visceral adipose tissue density (VATD). Using multivariable Cox proportional regression, we analyzed the association of clinical and transplant-related characteristics with overall survival (OS), relapse-free survival (RFS), and non-relapse mortality (NRM). In a multivariate regression model, patients with higher VATD had worse OS (HR 1.78; 95% confidence intervals CI 1.08–2.95, p = 0.02) and worse NRM (HR 2.31 95% CI 1.08–4.95, p = 0.02) than with lower VATD. Patients with lower levels of VAT also had worse RFS (HR 1.49 95% CI 1.03–2.15, p = 0.03). Sarcopenia and myosteatosis were not associated with outcomes. High pre-transplant VATD was associated with lower OS and higher NRM, and low pre-transplant VAT was associated with worse RFS in patients with NHL undergoing autologous HSCT.
- 12 September 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (12) , 1384-1389
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma
Recently there has been a growing interest in evaluating body composition as a marker for prognosis in cancer patients. The association of body composition parameters and outcomes has not been deeply investigated in patients with autologous hematopoietic stem cell transplantation (HSCT) recipients with non-Hodgkin lymphoma (NHL). We conducted a retrospective cohort study of 264 NHL patients who received autologous HSCT. PreHSCT abdominal CT scans at the levels of L3 were assessed for body composition measures. We evaluated sarcopenia, myosteatosis, high visceral adipose tissue (VAT) and high visceral adipose tissue density (VATD). Using multivariable Cox proportional regression, we analyzed the association of clinical and transplant-related characteristics with overall survival (OS), relapse-free survival (RFS), and non-relapse mortality (NRM). In a multivariate regression model, patients with higher VATD had worse OS (HR 1.78; 95% confidence intervals CI 1.08–2.95, p = 0.02) and worse NRM (HR 2.31 95% CI 1.08–4.95, p = 0.02) than with lower VATD. Patients with lower levels of VAT also had worse RFS (HR 1.49 95% CI 1.03–2.15, p = 0.03). Sarcopenia and myosteatosis were not associated with outcomes. High pre-transplant VATD was associated with lower OS and higher NRM, and low pre-transplant VAT was associated with worse RFS in patients with NHL undergoing autologous HSCT.